EMPLOYMENT AGREEMENTEmployment Agreement • February 22nd, 2022 • PTC Therapeutics, Inc. • Pharmaceutical preparations • New Jersey
This EMPLOYMENT AGREEMENT (the “Agreement”) is made as of October 28, 2019 (the “Effective Date”), by and between PTC Therapeutics, Inc., a Delaware corporation (the “Company”) and Matthew Klein (“Executive”). In consideration of the mutual covenants contained in this Agreement, the Company and Executive agree as follows:
Collaborative Research Agreement Amendment No. 10Collaborative Research Agreement • February 22nd, 2022 • PTC Therapeutics, Inc. • Pharmaceutical preparations
This Amendment No. 10 is made and entered into as of the last date of signature (the “Amendment 10 Effective Date") to that certain Collaborative Research Agreement dated September 30, 2015 (as amended, the “Agreement”) by and between National Taiwan University at No. 1, Sec. 4, Roosevelt Road, Taipei, 10617 Taiwan (R.O.C) (hereinafter “NTU”) and PTC Therapeutics GT, Inc. (formerly Agilis Biotherapeutics), a Delaware corporation duly organized under law and having an address at 6 Kimball Lane, Suite 320, Lynnfield, Massachusetts, 01940 USA (hereinafter “COMPANY”). Capitalized terms herein shall have the meaning ascribed to them in the Agreement. To the extent of any conflict with the prior amendments to the Agreement, this Amendment 10 supersedes the prior amendments.
